NLRP3 and vasculitis: Another study shows that TMAO can partially activate the inflammatory corpuscles of NLRP3 by inhibiting the SIRT3-SOD2-mtROS signaling pathway of apolipoprotein E (ApoE)−/− mice, thus promoting vasculitis (Chen et al., 2017).